{"id":"W1999447808","doi":"10.1046/j.1442-9071.2003.00646.x","title":"Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis","year":2003,"lang":"en","type":"article","venue":"Clinical and Experimental Ophthalmology","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Research Canada; Regional Municipality of Niagara","funders":"","keywords":"Medicine; Fexofenadine; Allergic conjunctivitis; Nedocromil Sodium; Terfenadine; Placebo; Regimen; Nedocromil; Anesthesia; Dermatology; Internal medicine; Asthma; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006041445,0.0003538245,0.001108207,0.0002461108,0.0002121298,0.0002532293,0.0003689143,0.0004806872,0.00154237],"category_scores_gemma":[0.0005891731,0.0001991943,0.0004602164,0.0001616634,0.0003640747,0.0002996001,0.0001851165,0.0005717804,0.0002387645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000276194,"about_ca_system_score_gemma":0.0003986079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004618477,"about_ca_topic_score_gemma":0.001061831,"domain_scores_codex":[0.9996474,0.0001501467,0.00004018683,0.00005949275,0.00006023021,0.00004269695],"domain_scores_gemma":[0.9997198,0.00006281134,0.0001046381,0.0000213994,0.00001737309,0.00007394283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5603341,0.04702424,0.0145444,0.001957462,0.0009531511,0.000419145,0.0002919985,0.001100383,0.2146313,0.0001206575,0.0006270625,0.1579962],"study_design_scores_gemma":[0.1630951,0.7776701,0.03607536,0.0000935776,0.0004733961,0.0005986998,0.00008071271,0.0009607797,0.0186178,0.00003962668,0.002268284,0.00002654457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973503,0.002087359,0.0001167628,0.0000344915,0.00003067132,0.0001636065,0.00003199528,0.000009255751,0.0001755426],"genre_scores_gemma":[0.9977453,0.0009571527,0.0006499297,0.00008157248,0.00005515555,0.0001671058,0.000101563,0.000002407359,0.0002397999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00154237,"threshold_uncertainty_score":0.005159736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03501908597281973,"score_gpt":0.3493415841908047,"score_spread":0.314322498217985,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}